| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/01/2004 | WO2004027057A1 Method of analyzing organelle-localized protein and materials for analysis |
| 04/01/2004 | WO2004027054A1 Thermostable rna ligase from thermus phage |
| 04/01/2004 | WO2004027053A1 Chicken astrovirus type 2 |
| 04/01/2004 | WO2004027048A2 High titer recombinant aav production |
| 04/01/2004 | WO2004027042A2 Isolation and use of ryanodine receptors |
| 04/01/2004 | WO2004027041A2 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use |
| 04/01/2004 | WO2004027039A2 Protein modification and maintenance molecules |
| 04/01/2004 | WO2004027037A2 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS |
| 04/01/2004 | WO2004027036A2 Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine |
| 04/01/2004 | WO2004027034A2 Methods for assessing the ability of hiv patients to restrict hiv replication |
| 04/01/2004 | WO2004027033A2 Lentiviral vector-mediated gene transfer and uses thereof |
| 04/01/2004 | WO2004027026A2 Improved methods for preparing highly active april ligand polypeptides |
| 04/01/2004 | WO2004027020A2 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 04/01/2004 | WO2004027019A2 Improved raav expression systems for genetic modification of specific capsid proteins |
| 04/01/2004 | WO2004026907A2 Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals |
| 04/01/2004 | WO2004026906A1 Method for identifying inhibitors in vivo |
| 04/01/2004 | WO2004026905A2 Transporter/channel proteins |
| 04/01/2004 | WO2004026904A1 Rfamide-related peptide precursor proteins and rfamide peptides |
| 04/01/2004 | WO2004026903A2 Live antenuated parasite vaccine |
| 04/01/2004 | WO2004026902A1 Process for production of cephalosporin c |
| 04/01/2004 | WO2004026901A1 M. paratuberculosis specific abc-transporter operon |
| 04/01/2004 | WO2004026900A1 Vaccine |
| 04/01/2004 | WO2004026899A1 Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof |
| 04/01/2004 | WO2004026897A1 Wt1 substitution peptides |
| 04/01/2004 | WO2004026895A2 Gd2 ligands |
| 04/01/2004 | WO2004026893A2 Synthetic chemokines labeled at selected positions |
| 04/01/2004 | WO2004026888A2 Toll-like receptor 9 (tlr9) from various mammalian species |
| 04/01/2004 | WO2004026772A2 Ammonia-oxidizing bacteria and methods of using and detecting the same |
| 04/01/2004 | WO2004026407A1 Use of inhibitors of compounds involved in the jun kinase (jnk) biochemical cellular pathway for the treatment or diagnosis of liposarcomas |
| 04/01/2004 | WO2004026338A1 Ihnv g protein for immune stimulation |
| 04/01/2004 | WO2004026332A1 Methods of increasing platelet and hematopoietic stem cell production |
| 04/01/2004 | WO2004026331A1 Peptides inhibiting specific cleaving activities of presenilins |
| 04/01/2004 | WO2004026329A1 Peptides and related molecules that modulate nerve growth factor activity |
| 04/01/2004 | WO2004026328A1 Compstatin analogs with improved activity |
| 04/01/2004 | WO2004026327A1 Homing peptides to receptors of heart vasculature |
| 04/01/2004 | WO2004026265A2 Compositions and methods for treatment of herpesvirus infections |
| 04/01/2004 | WO2004026260A2 Prophylactic and therapeutic hiv aptamers |
| 04/01/2004 | WO2004026251A2 Process for decreasing aggregate levels of pegylated protein |
| 04/01/2004 | WO2004026228A2 Method for reducing morbidity and mortality in critically ill patients |
| 04/01/2004 | WO2004018681A3 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 04/01/2004 | WO2004013631A3 Compositions and methods for diagnosis and therapy of cancer |
| 04/01/2004 | WO2004009762A9 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 04/01/2004 | WO2004007723A3 Genes |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2004005473A3 Hcv fusion proteins with modified ns3 domains |
| 04/01/2004 | WO2004003165A9 Novel polynucleotide and polypeptide sequences and uses thereof |
| 04/01/2004 | WO2004003153A8 Live replicating spumavirus vector |
| 04/01/2004 | WO2004003014A3 Gene for increased somatic recombination |
| 04/01/2004 | WO2004003008A3 Peptides for inducing apoptosis in tumor cells |
| 04/01/2004 | WO2003106495A3 Humanized monoclonal antiboby hpam4 |
| 04/01/2004 | WO2003100082A8 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 04/01/2004 | WO2003100016A3 Protein modification and maintenance molecules |
| 04/01/2004 | WO2003099830A3 Cardiolipin compositions, methods of preparation and use |
| 04/01/2004 | WO2003097833A3 Method for the functional artificial evolution of polynucleotide sequences, recombinant polynucleotides obtained and peptides, polypeptides and proteins coded by same |
| 04/01/2004 | WO2003097799A3 HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS |
| 04/01/2004 | WO2003096022A3 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 04/01/2004 | WO2003095642A3 Polyepitopes and mini-genes for cancer treatment |
| 04/01/2004 | WO2003093492A3 Compositions and methods for determining susceptibility of hepatitis c virus to anti-viral drugs |
| 04/01/2004 | WO2003093461A3 Genomic library of cyanophage s-2l and functional analysis |
| 04/01/2004 | WO2003091383A3 Epha2 antigen t epitopes |
| 04/01/2004 | WO2003091381A3 Height-related gene |
| 04/01/2004 | WO2003090667A3 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus |
| 04/01/2004 | WO2003089934A3 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1 |
| 04/01/2004 | WO2003087840A3 Protein involved in cancer |
| 04/01/2004 | WO2003087138A3 Methods for identifying polypeptide factors interacting with rna |
| 04/01/2004 | WO2003086491B1 Tissue defect dressings comprising a keratin network |
| 04/01/2004 | WO2003084566A3 Proteins involved in the regulation of energy homeostasis |
| 04/01/2004 | WO2003083124A3 Peptide epitopes common to antigens of the same multigene family |
| 04/01/2004 | WO2003083048A3 Novel secreted proteins and their uses |
| 04/01/2004 | WO2003082911A3 Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics |
| 04/01/2004 | WO2003081978A3 Generation of plants with improved pathogen resistance |
| 04/01/2004 | WO2003080663A3 Tenascin-w compositions and uses thereof |
| 04/01/2004 | WO2003078602A3 Methods of expressing non-endogenous g protein coupled receptors in cells |
| 04/01/2004 | WO2003070749A3 Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
| 04/01/2004 | WO2003070748A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/01/2004 | WO2003066877A3 Compositions and methods relating to hepatic specific genes and proteins |
| 04/01/2004 | WO2003064446A3 Plasma protein-binding peptides from bacterial curli |
| 04/01/2004 | WO2003063770A3 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 04/01/2004 | WO2003062270B1 Fluorescent protein from aequorea coerulscens and uses therof |
| 04/01/2004 | WO2003060090A3 Novel cytokine zcytor17 ligand |
| 04/01/2004 | WO2003059053A3 Rabbit nuclear cloning method and uses thereof |
| 04/01/2004 | WO2003050243A3 Novel genes encoding colon cancer antigens |
| 04/01/2004 | WO2003048186A3 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 04/01/2004 | WO2003045990A3 Protein-protein interactions involving transforming growth factor beta signalling |
| 04/01/2004 | WO2003040286A3 Cdw92 molecule induced immunomodulation |
| 04/01/2004 | WO2003040180A3 Genes of corynebacterium glutamicum encoding for genetic stability, gene expression and folding proteins |
| 04/01/2004 | WO2003031940A3 Structural and cytoskeleton-associated proteins |
| 04/01/2004 | WO2003029405A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 04/01/2004 | WO2003029282A3 Tumor-peptide antigens from the human prdi-bf1-protein |
| 04/01/2004 | WO2003012044A9 Hagfish cathelin-associated antimicrobial peptides and genes |
| 04/01/2004 | WO2003008440A3 Nucleic acid molecules encoding proteins essential for plant growth |
| 04/01/2004 | WO2003004678A3 Novel receptors |
| 04/01/2004 | WO2002092758A3 Gastrokines and derived peptides including inhibitors |
| 04/01/2004 | WO2002085286A3 Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals |
| 04/01/2004 | WO2002083847A3 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 04/01/2004 | WO2002081676A3 Non-pathogenic bacterial recipient strain of a bacterium containing mycolic acid, method for the production thereof and use of the same |
| 04/01/2004 | WO2002077180A3 Novel nucleic acids and polypeptides |
| 04/01/2004 | WO2002077012A3 Human papilloma virus immunoreative peptides |
| 04/01/2004 | WO2002072774A3 Novel human transporter proteins and polynucleotides encoding the same |
| 04/01/2004 | WO2002072601A3 Apoptosis modulator bcl-b and methods for making and using same |